High expression profiles of PTGER1 and PTGER3 in obstructed ureters could contribute to new treatment approaches, complementing the therapy of urolithiasis as an alternative to the widespread use of COX inhibitors to provide superior efficacy while minimizing potential side effects of current therapy strategies. This evidence concerns the gene PTGER1 and urolithiasis.